Statistics
Publications
5
Citations
385
H-Index
5
Active since
2016
Shizhong Ke is an author at Harvard University specializing in oncology, medicine, and molecular oncology.
Publications per year
2016–2024
5
5
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Kazuhiro Koikawa, Shin Kibe, Futoshi Suizu et al. · Cell · 2021 · 241 citations · Full text
Medicine, Immunology, Oncology +11
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
Lin Wang, Dan Wang, Olmo Sonzogni et al. · Cell Reports · 2022 · 56 citations · Full text
Medicine, Oncology, Pharmacology +17
Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer
Fabin Dang, Li Nie, Jin Zhou et al. · Nature Communications · 2021 · 50 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 5